Shares of Diploma PLC (LON:DPLM – Get Free Report) have earned a consensus rating of “Moderate Buy” from the eight brokerages that are covering the company, MarketBeat.com reports. Three analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is GBX 6,086.25.
A number of brokerages have weighed in on DPLM. Berenberg Bank upped their price target on Diploma from GBX 6,600 to GBX 7,500 and gave the company a “buy” rating in a research report on Thursday, March 19th. Stifel Nicolaus lifted their price objective on Diploma from GBX 6,200 to GBX 6,800 and gave the company a “buy” rating in a report on Thursday, March 19th. Shore Capital Group restated a “hold” rating on shares of Diploma in a research note on Wednesday, March 18th. Peel Hunt reaffirmed a “buy” rating and issued a GBX 6,150 target price on shares of Diploma in a report on Friday, December 19th. Finally, Jefferies Financial Group increased their target price on shares of Diploma from GBX 5,200 to GBX 5,700 and gave the stock a “hold” rating in a research report on Monday.
Check Out Our Latest Report on Diploma
Diploma Trading Down 1.0%
Insider Transactions at Diploma
In other news, insider Johnny Thomson sold 30,000 shares of the business’s stock in a transaction that occurred on Friday, January 16th. The stock was sold at an average price of GBX 5,668, for a total value of £1,700,400. Also, insider Katie Bickerstaffe purchased 352 shares of the firm’s stock in a transaction that occurred on Wednesday, January 14th. The shares were acquired at an average price of GBX 5,645 per share, for a total transaction of £19,870.40. Over the last 90 days, insiders bought 1,352 shares of company stock valued at $7,704,540. Corporate insiders own 1.14% of the company’s stock.
Diploma Company Profile
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Read More
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.
